Incidence Of Hepatitis In Intensive Care Unit

NCT03456037 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-03-07

No results posted yet for this study

Summary

The aim is to investigate incidence of HBsAg, anti-HCV in serum samples and evaluation of biomarkers taken from patients who were followed the intensive care unit of Sakarya University Training and Research Hospital and The intensive care unit attracts attention by making health workers more susceptible to the risk of hepatitis.

Conditions

  • Intensive Care Unit

Interventions

OTHER

hepatitis viruses

There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.The aim is to investigate incidence of HBsAg, anti-HCV in serum samples and evaluation of biomarkers taken from patients who were followed the intensive care unit of Sakarya University Training and Research Hospital.

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Principal Investigators

  • Havva Sayhan,, Assis Prof · Sakarya University Research and Training Hospital

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-05-01
Completion
2019-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03456037 on ClinicalTrials.gov